Loading…
Amneal Pharmaceuticals, Inc. is projected to rise to $21.93 by 2027, a +29% move from its current price of $17.01. AMRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $16.74 | $17.02 | $17.30 | +0.05% |
| Jul 14 | $16.63 | $17.03 | $17.43 | +0.10% |
| Jul 15 | $16.55 | $17.03 | $17.53 | +0.14% |
| Jul 16 | $16.49 | $17.04 | $17.62 | +0.19% |
| Jul 17 | $16.43 | $17.05 | $17.70 | +0.24% |
| Jul 18 | $16.38 | $17.06 | $17.77 | +0.29% |
| Jul 19 | $16.33 | $17.07 | $17.83 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $16.33 | $17.07 | $17.83 | +0.34% |
| Week 2 | $16.09 | $17.13 | $18.22 | +0.68% |
| Week 3 | $15.92 | $17.18 | $18.54 | +1.02% |
| Week 4 | $15.79 | $17.24 | $18.82 | +1.36% |
| Week 5 | $15.68 | $17.30 | $19.08 | +1.70% |
| Week 6 | $15.59 | $17.36 | $19.33 | +2.04% |
| Week 7 | $15.51 | $17.42 | $19.56 | +2.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company that develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE.
The Affordable Medicines segment offers dosage forms and delivery systems, including immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. Amneal was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc.
in 2018. It was founded in 2002 and is headquartered in Bridgewater, New Jersey.
AMRX is currently trading at $16.34, with a market cap of $5.21B and a rank of 1314. The near-term forecast positions the stock at an average of $16.34 for 2026, within a range from $11.81 to $22.16, suggesting upside potential around the current level. The long-range outlook shows a rising trajectory in average prices and substantial upside in later years.
These projections imply continued bullish momentum, with higher target levels anticipated through 2030 and beyond.
A major floor 35.4% below — a decisive break under it would weaken the trend.
The nearest floor, 25.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.8% away) — a breakout level to watch.
A major ceiling 19.5% above — clearing it would confirm fresh momentum.
Key AMRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AMRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.99 | Buy | $17.02 | Sell |
| MA 10 | $17.09 | Sell | $16.94 | Buy |
| MA 20 | $16.79 | Buy | $16.45 | Buy |
| MA 50 | $14.50 | Buy | $15.14 | Buy |
| MA 100 | $13.75 | Buy | $14.15 | Buy |
| MA 200 | $12.89 | Buy | $12.91 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.77 | Neutral |
| Stoch RSI (14) | 2.80 | Buy |
| CCI (20) | 36.51 | Neutral |
| Williams %R (14) | -25.62 | Info |
| MACD (12,26,9) | -0.13 | Sell |
| ROC (12) | 2.10 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 74.38 | Neutral |
| TRIX (15) | 0.91 | Buy |
| Awesome (5,34) | 1.65 | Buy |
| Ultimate (7,14,28) | 50.16 | Neutral |
| Momentum (10) | -0.31 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 16.96 | Buy |
| ADX (14) | 43.03 | Buy |
| ATR (14) | 0.19 | Info |
In the near term, the technical picture is described as BULLISH with RSI(14) at 80. The near-term moving averages show SMA50 at $12.98 and SMA200 at $12.22, indicating a positive setup relative to recent prices. Support is identified at $11.81 and resistance at $16.34, with the 30-day trading range spanning from $13.81 to $19.33.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.81 | $17.01 | $23.08 | 0% | Neutral | |
| $17.96 | $21.93 | $27.99 | +29% | Bullish | |
| $20.10 | $25.01 | $32.79 | +47% | Bullish | |
| $24.19 | $30.56 | $40.92 | +80% | Bullish | |
| $30.84 | $39.49 | $53.82 | +132% | Bullish | |
| $35.37 | $45.83 | $63.46 | +169% | Bullish | |
| $39.89 | $52.28 | $73.42 | +207% | Bullish | |
| $43.11 | $57.08 | $81.20 | +236% | Bullish | |
| $46.35 | $61.99 | $89.24 | +264% | Bullish | |
| $52.70 | $71.15 | $103.57 | +318% | Bullish | |
| $83.52 | $117.61 | $179.40 | +591% | Bullish | |
| $188.92 | $285.31 | $466.51 | +15.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.81 | $17.01 | $20.41 | +0.00% |
| August 2026 | $15.18 | $17.76 | $21.24 | +4.43% |
| September 2026 | $15.11 | $17.77 | $21.42 | +0.06% |
| October 2026 | $15.12 | $17.86 | $21.67 | +0.50% |
| November 2026 | $15.60 | $18.48 | $22.55 | +3.49% |
| December 2026 | $15.83 | $18.82 | $23.08 | +1.84% |
Click any year to see its month-by-month AMRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Amneal Pharmaceuticals, Inc.'s 2026 outlook centres on $17.01, within a $11.81 to $23.08 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, AMRX could reach as high as $27.99, with a base case around $21.93 and support toward $17.96 — roughly +29% from $17.01. Momentum favours further upside here.
Expect AMRX to range from $20.10 to $32.79 through 2028. The $25.01 average target implies a +47% move from current prices. That is up +14% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The AMRX price prediction for 2029 points to an average of $30.56 (low $24.19, high $40.92) — a potential gain of +80% on today's $17.01. Momentum favours further upside here.
In 2030, AMRX is projected to trade between $30.84 and $53.82, averaging $39.49 — a potential gain of +132% from today's $17.01. That is up +29% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Amneal Pharmaceuticals, Inc.'s 2031 outlook centres on $45.83, within a $35.37 to $63.46 range. That is up +16% on the projected 2030 average. That marks a +169% change versus current levels. Momentum favours further upside here.
By 2032, AMRX could reach as high as $73.42, with a base case around $52.28 and support toward $39.89 — roughly +207% from $17.01. Buyers look set to stay in control over this stretch.
Expect AMRX to range from $43.11 to $81.20 through 2033. The $57.08 average target implies a +236% move from current prices. That is up +9% on the projected 2032 average. Momentum favours further upside here.
The AMRX price prediction for 2034 points to an average of $61.99 (low $46.35, high $89.24) — a potential gain of +264% on today's $17.01. Buyers look set to stay in control over this stretch.
In 2035, AMRX is projected to trade between $52.70 and $103.57, averaging $71.15 — a potential gain of +318% from today's $17.01. That is up +15% on the projected 2034 average. Momentum favours further upside here.
Amneal Pharmaceuticals, Inc.'s 2040 outlook centres on $117.61, within a $83.52 to $179.40 range. That is up +65% on the projected 2035 average. That marks a +591% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, AMRX could reach as high as $466.51, with a base case around $285.31 and support toward $188.92 — roughly +15.8x from $17.01. Momentum favours further upside here.
Investing $1,000 in AMRX today (≈ 58.788948 AMRX) could be worth
$16,773.26
+$15,773.26 (+1577%) by 2050 · US Dollar
Based on the average projected AMRX price of $285.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AMRXwould be worth at today's price.
$1,000 invested in AMRX on Jul 10, 2025 (≈ 119.189506 AMRX) would be worth
$2,027.41
+$1,027.41 (+102.7%) today · 2.03× · US Dollar
Based on a AMRX entry price of $8.39 vs. today's $17.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.15 | $991.84 | -0.8% |
| 1 month ago | $15.32 | $1,110.31 | +11.0% |
| 3 months ago | $12.54 | $1,356.46 | +35.6% |
| 6 months ago | $12.98 | $1,310.48 | +31.0% |
| 1 year ago | $8.39 | $2,027.41 | +102.7% |
| All time (5.0y) ago | $4.68 | $3,634.62 | +263.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AMRX forecast.
Our base-case forecast reaches $34.00 around 2030.
Implied market cap at $34.00: $10.86B
The multi-year forecast shows a clear upward path in average prices and strong ROIs. For 2027 the avg is $20.55 with an ROI of 25.8% and a BULLISH sentiment; 2028's avg is $23.50 (ROI 43.8%), 2029's avg $27.14 (ROI 66.1%), and 2030's avg $36.24 (ROI 121.8%). By 2035 the avg reaches $58.36 (ROI 257.2%), and by 2040 the avg is $97.64 (ROI 497.5%).
The 2050 forecast shows an avg of $226.31 (ROI 1285%) with a BULLISH sentiment. These figures illustrate a sustained bullish trajectory over the long term, with the max values climbing to $52.08 in 2030 and as high as $408.17 by 2050. While these numbers indicate meaningful upside, they are estimates and not guarantees, and actual results can vary with market conditions.
Tap a question to reveal the answer.
Avg $36.24, min $27.13, max $52.08, ROI 121.8%, sentiment BULLISH.
The forecast shows rising averages and positive ROIs from 2027 onward, with 2027 avg $20.55 (ROI 25.8%), 2028 avg $23.50 (ROI 43.8%), 2029 avg $27.14 (ROI 66.1%), 2030 avg $36.24 (ROI 121.8%), and 2050 avg $226.31 (ROI 1285%). The longer horizon is bullish, but these are estimates, not guarantees.
Yes. The 2031 max is $60.77, with higher maxima in subsequent years (2032 max $67.24, 2033 max $77.28; 2040 max $161.64; 2050 max $408.17).
Current price is $16.34 and market cap is $5.21B. The stock is ranked 1314 by market capitalization.
RSI(14) is 80 with a BULLISH sentiment. SMA50 is $12.98 and SMA200 is $12.22. Support is at $11.81 and resistance at $16.34. The 30-day range is $13.81 to $19.33.
Amneal Pharmaceuticals, Inc. Community Discussion
0Share your Amneal Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.